Trends in the rates of health-care providers’ recommendation for HPV vaccine from 2012 to 2018: a multi-round cross-sectional analysis of the health information national trends survey
The 2012 report of the President’s Cancer Panel highlighted the overriding contribution of missed clinical opportunities to suboptimal HPV vaccination coverage. Since then, it remains unknown whether the rates of provider recommendations for the HPV vaccine in the US population have increased. We co...
Main Authors: | Joël Fokom Domgue, Robert K. Yu, Sanjay Shete |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2021-09-01
|
Series: | Human Vaccines & Immunotherapeutics |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/21645515.2021.1917235 |
Similar Items
-
Recommending HPV vaccination at age 9 to reduce health disparities: Communication challenges and opportunities
by: Tamera Coyne-Beasley, et al.
Published: (2023-01-01) -
Healthcare Provider Recommendations and Observed Changes in HPV Vaccination Acceptance during the COVID-19 Pandemic
by: Ikponmwosa Osaghae, et al.
Published: (2022-09-01) -
Barriers to the assessment and recommendation of HPV vaccination among healthcare providers in Texas
by: Onyema G. Chido-Amajuoyi, et al.
Published: (2024-06-01) -
HPV vaccination in Africa in the COVID-19 era: a cross-sectional survey of healthcare providers’ knowledge, training, and recommendation practices
by: Joel Fokom Domgue, et al.
Published: (2024-01-01) -
The influence of parent–child gender on intentions to refuse HPV vaccination due to safety concerns/side effects, National Immunization Survey – Teen, 2010–2019
by: Onyema Greg Chido-Amajuoyi, et al.
Published: (2022-11-01)